asduter 30mg tableta
vipharm s.a., ożarów mazowiecki array - 14774 aripiprazol - tableta - 30mg - aripiprazol
explemed 10mg tableta
egis pharmaceuticals plc, budapešť array - 14774 aripiprazol - tableta - 10mg - aripiprazol
explemed 15mg tableta
egis pharmaceuticals plc, budapešť array - 14774 aripiprazol - tableta - 15mg - aripiprazol
explemed rapid 10mg tableta dispergovatelná v ústech
egis pharmaceuticals plc, budapešť maĎarsko - 14774 aripiprazol - tableta dispergovatelná v ústech - 10mg - aripiprazol
explemed rapid 15mg tableta dispergovatelná v ústech
egis pharmaceuticals plc, budapešť maĎarsko - 14774 aripiprazol - tableta dispergovatelná v ústech - 15mg - aripiprazol
restigulin 10mg tableta
gedeon richter plc., budapešť array - 14774 aripiprazol - tableta - 10mg - aripiprazol
restigulin 15mg tableta
gedeon richter plc., budapešť array - 14774 aripiprazol - tableta - 15mg - aripiprazol
lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - cytostatika - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.